Clinical Trial Update: Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating budesonide inhalation suspension for efficacy and safety in chronic rhinosinusitis with polyposis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Polyposis

Drugs mentioned

• Budesonide Inhalation Suspension (budesonide)

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Chronic Rhinosinusitis With Polyposis | Phase 3 | Status: COMPLETED